Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

133.40
Delayed Data
As of 4:00pm ET
 -1.23 / -0.91%
Today’s Change
96.18
Today|||52-Week Range
145.42
+9.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues786.3M831.0M850.0M893.0M
 
 
 
 
 
Cost of Goods Sold52.5M47.3M50.0M62.0M
 
 
 
 
 
Depreciation And Amortization100.7M100.7M99.0M102.0M
 
 
 
 
 
 
Operating ExpensesGross Income633.2M683.0M701.0M729.0M
 
 
 
 
 
General Expenses425.8M465.0M481.0M464.0M
 
 
 
 
 
Research And Development195.7M206.0M219.0M199.0M
 
 
 
 
 
Total Operating Expenses578.9M613.0M630.0M628.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income207.4M218.0M220.0M265.0M
 
 
 
 
 
Extraordinary Charge-40.9M-90.0M-37.0M-58.0M
 
 
 
 
 
Interest Expense On Debt24.8M25.0M23.0M23.0M
 
 
 
 
 
Other Expenses12.4M-1.0M30.0M18.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income158.1M104.0M194.0M206.0M
 
 
 
 
 
Income Taxes-63.8M-11.0M-24.0M-41.0M
 
 
 
 
 
Net Income94.3M93.0M170.0M165.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS224.2M225.0M224.0M224.0M
 
 
 
 
 
Shares To Calculate EPS Diluted226.1M226.0M226.0M225.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.42$0.41$0.75$0.73
 
 
 
 
 
EPS Diluted$0.42$0.41$0.75$0.73